Q1 met expectations, but the guidance downgrade was a surprise
08/05/25 -"Demant’s Q1 results met market expectations. Growth in Hearing Care was counterbalanced by weakness in Hearing Aids. Meanwhile, Diagnostics remained stable. However, profitability fell short of ..."
Pages
65
Language
English
Published on
08/05/25
You may also be interested by these reports :
23/10/26
SSB delivered an in-line Q3 26, with revenue and underlying EBITDA in line with consensus. Consumables continued to lead growth, while equipment grew ...
22/10/26
After a failed bid by Thermo Fisher and persistent rumours in recent years, Qiagen shareholders now have a second opportunity. Although shareholder ...
22/10/26
Sartorius reported a strong Q3 26, with revenue (+3.0%) and underlying EBITDA (+4.1%) comfortably ahead of consensus. Operational growth accelerated ...
20/10/26
EssilorLuxottica recorded strong growth in Q3 2026, ahead of market expectations, with revenue up 9.0% YoY and 7.2% at constant currency. Management ...